Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
NCT02970968
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
152
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroparesis
Interventions
DRUG:
VLY-686 (Tradipitant)
OTHER:
Placebo
Sponsor
Vanda Pharmaceuticals